Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression

Gamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticanc...

Full description

Bibliographic Details
Main Authors: Andrey A. Rosenkranz, Tatiana A. Slastnikova, Tatiana A. Karmakova, Maria S. Vorontsova, Natalia B. Morozova, Vasiliy M. Petriev, Alexey S. Abrosimov, Yuri V. Khramtsov, Tatiana N. Lupanova, Alexey V. Ulasov, Raisa I. Yakubovskaya, Georgii P. Georgiev, Alexander S. Sobolev
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01331/full
id doaj-1245657b71f44cc682e9f85173769347
record_format Article
spelling doaj-1245657b71f44cc682e9f851737693472020-11-24T23:28:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-11-01910.3389/fphar.2018.01331411492Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR OverexpressionAndrey A. Rosenkranz0Andrey A. Rosenkranz1Tatiana A. Slastnikova2Tatiana A. Karmakova3Maria S. Vorontsova4Natalia B. Morozova5Vasiliy M. Petriev6Vasiliy M. Petriev7Alexey S. Abrosimov8Yuri V. Khramtsov9Tatiana N. Lupanova10Alexey V. Ulasov11Raisa I. Yakubovskaya12Georgii P. Georgiev13Alexander S. Sobolev14Alexander S. Sobolev15Institute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaFaculty of Biology, Lomonosov Moscow State University, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaFaculty of Biology, Lomonosov Moscow State University, Moscow, RussiaGamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticancer agent if delivered precisely into the nuclei of tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery of short-range therapeutic cargoes into the nuclei of target cells are perspective candidates for specific intracellular delivery of AE emitters. The objective of this study was to evaluate the in vitro and in vivo efficacy of 111In attached MNTs to kill human bladder cancer cells overexpressing epidermal growth factor receptor (EGFR). The cytotoxicity of 111In delivered by the EGFR-targeted MNT (111In-MNT) was greatly enhanced on EJ-, HT-1376-, and 5637-expressing EGFR bladder cancer cell lines compared with 111In non-targeted control. In vivo microSPECT/CT imaging and antitumor efficacy studies revealed prolonged intratumoral retention of 111In-MNT with t½ = 4.1 ± 0.5 days as well as significant dose-dependent tumor growth delay (up to 90% growth inhibition) after local infusion of 111In-MNT in EJ xenograft-bearing mice.https://www.frontiersin.org/article/10.3389/fphar.2018.01331/fullmodular nanotransportersdrug deliveryintracellular transportbladder cancerradionuclide therapyAuger electron emitter
collection DOAJ
language English
format Article
sources DOAJ
author Andrey A. Rosenkranz
Andrey A. Rosenkranz
Tatiana A. Slastnikova
Tatiana A. Karmakova
Maria S. Vorontsova
Natalia B. Morozova
Vasiliy M. Petriev
Vasiliy M. Petriev
Alexey S. Abrosimov
Yuri V. Khramtsov
Tatiana N. Lupanova
Alexey V. Ulasov
Raisa I. Yakubovskaya
Georgii P. Georgiev
Alexander S. Sobolev
Alexander S. Sobolev
spellingShingle Andrey A. Rosenkranz
Andrey A. Rosenkranz
Tatiana A. Slastnikova
Tatiana A. Karmakova
Maria S. Vorontsova
Natalia B. Morozova
Vasiliy M. Petriev
Vasiliy M. Petriev
Alexey S. Abrosimov
Yuri V. Khramtsov
Tatiana N. Lupanova
Alexey V. Ulasov
Raisa I. Yakubovskaya
Georgii P. Georgiev
Alexander S. Sobolev
Alexander S. Sobolev
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
Frontiers in Pharmacology
modular nanotransporters
drug delivery
intracellular transport
bladder cancer
radionuclide therapy
Auger electron emitter
author_facet Andrey A. Rosenkranz
Andrey A. Rosenkranz
Tatiana A. Slastnikova
Tatiana A. Karmakova
Maria S. Vorontsova
Natalia B. Morozova
Vasiliy M. Petriev
Vasiliy M. Petriev
Alexey S. Abrosimov
Yuri V. Khramtsov
Tatiana N. Lupanova
Alexey V. Ulasov
Raisa I. Yakubovskaya
Georgii P. Georgiev
Alexander S. Sobolev
Alexander S. Sobolev
author_sort Andrey A. Rosenkranz
title Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
title_short Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
title_full Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
title_fullStr Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
title_full_unstemmed Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
title_sort antitumor activity of auger electron emitter 111in delivered by modular nanotransporter for treatment of bladder cancer with egfr overexpression
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-11-01
description Gamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticancer agent if delivered precisely into the nuclei of tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery of short-range therapeutic cargoes into the nuclei of target cells are perspective candidates for specific intracellular delivery of AE emitters. The objective of this study was to evaluate the in vitro and in vivo efficacy of 111In attached MNTs to kill human bladder cancer cells overexpressing epidermal growth factor receptor (EGFR). The cytotoxicity of 111In delivered by the EGFR-targeted MNT (111In-MNT) was greatly enhanced on EJ-, HT-1376-, and 5637-expressing EGFR bladder cancer cell lines compared with 111In non-targeted control. In vivo microSPECT/CT imaging and antitumor efficacy studies revealed prolonged intratumoral retention of 111In-MNT with t½ = 4.1 ± 0.5 days as well as significant dose-dependent tumor growth delay (up to 90% growth inhibition) after local infusion of 111In-MNT in EJ xenograft-bearing mice.
topic modular nanotransporters
drug delivery
intracellular transport
bladder cancer
radionuclide therapy
Auger electron emitter
url https://www.frontiersin.org/article/10.3389/fphar.2018.01331/full
work_keys_str_mv AT andreyarosenkranz antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT andreyarosenkranz antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT tatianaaslastnikova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT tatianaakarmakova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT mariasvorontsova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT nataliabmorozova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT vasiliympetriev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT vasiliympetriev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT alexeysabrosimov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT yurivkhramtsov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT tatiananlupanova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT alexeyvulasov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT raisaiyakubovskaya antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT georgiipgeorgiev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT alexanderssobolev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
AT alexanderssobolev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression
_version_ 1725548669290151936